Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature.

Efird, Jimmy T; Anderson, Ethan J; Jindal, Charulata; Suzuki, Ayako

Efird, Jimmy T; Anderson, Ethan J; Jindal, Charulata; Suzuki, Ayako.

Affiliation

Efird JT; VA Cooperative Studies Program Coordinating Center, Boston, MA 02130, USA.
Anderson EJ; Department of Radiation Oncology, School of Medicine, Case Western Reserve University, Cleveland, OH 44105, USA.
Jindal C; Department of Pharmaceutical Sciences and Experimental Therapeutics, Fraternal Order of Eagles Diabetes Research Center, Abboud Cardiovascular Research Center, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
Suzuki A; Harvard Medical School, Harvard University, Boston, MA 02115, USA.

Curr Pharm Des ; 28(21): 1695-1702, 2022.

Article in En | MEDLINE | ID: mdl-35440302

Subject(s)

COVID-19 Drug Treatment; Adrenal Cortex Hormones/therapeutic use; Humans; SARS-CoV-2; Vitamin D/therapeutic use; Vitamins

Key words

Anti-inflammatory; COVID-19; SARS-CoV-2; corticosteroids; cytokine storm; vitamin D

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United Arab Emirates

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google